Galenica AG (VIE:GALE)

Market Cap	4.31B -6.0%
Revenue (ttm)	4.64B +6.4%
Net Income	172.44M -17.2%
EPS	3.45 -17.4%
Shares Out	n/a
PE Ratio	24.97
Forward PE	20.26
Dividend	2.72 (3.13%)
Ex-Dividend Date	Apr 23, 2026

Volume	n/a
Open	87.25
Previous Close	87.60
Day's Range	87.05 - 87.35
52-Week Range	85.60 - 112.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 9, 2027

About Galenica AG

Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and prod...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1927
• Employees: 6,623
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: GALE

Financial Performance

In 2025, Galenica AG's revenue was 4.15 billion, an increase of 5.48% compared to the previous year's 3.93 billion. Earnings were 181.10 million, a decrease of -1.01%.

Financial numbers in CHF

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 20, 2026

Data Sources Report a data error